# KNDC1

## Overview
The KNDC1 gene encodes the protein kinase non-catalytic C-lobe domain containing 1, which is a Ras guanine nucleotide exchange factor (RasGEF) involved in various cellular processes. This protein plays a significant role in neuronal development, particularly in the regulation of dendritic growth through the Ras-Raf-MAP kinase signaling pathway (Hayashi2017The). Additionally, KNDC1 is implicated in cellular senescence, especially in endothelial cells, where its expression increases with age, contributing to a senescence-like phenotype (ZHANG2014KNDC1). The protein's interactions with other cellular components, such as microtubule-associated protein 2 (MAP2) and its involvement in the p53 signaling pathway, underscore its importance in cell signaling and growth regulation (Ji2018Effect; Duan2016Genetic). Furthermore, KNDC1 has been associated with various clinical conditions, including its potential role as a tumor suppressor in ovarian cancer and its involvement in vascular aging, highlighting its significance in both normal physiology and disease states (p&gt; Yu2020&lt; KNDC1; Ji2018Effect).

## Structure


## Function
The KNDC1 gene encodes a protein known as kinase non-catalytic C-lobe domain containing 1, which functions as a Ras guanine nucleotide exchange factor (RasGEF). This protein is primarily recognized for its role in neuronal development, particularly in the regulation of dendritic growth. In the brain, KNDC1 is involved in the Ras-Raf-MAP kinase signaling pathway, which is crucial for neuronal dendrite development (Hayashi2017The). The protein is typically active in the cytoplasm, where it influences cell signaling and growth processes.

In endothelial cells, KNDC1 has been implicated in cellular senescence. Studies have shown that as human umbilical vein endothelial cells (HUVECs) age, there is an increase in the transcription and expression of KNDC1, which is associated with a senescence-like phenotype. This includes slowed growth and halted proliferation (ZHANG2014KNDC1). The overexpression of KNDC1 in these cells has been linked to increased senescence, characterized by features such as positive senescence-associated β-galactosidase staining and enlarged cell morphology (Ji2018Effect). These findings suggest that KNDC1 plays a role in promoting cellular senescence by modulating the p53 signaling pathway and reactive oxygen species levels (Ji2018Effect).

## Clinical Significance
The KNDC1 gene has been implicated in various diseases and conditions through mutations, altered expression levels, and changes in its normal interactions. In ovarian cancer (OC), KNDC1 is significantly downregulated compared to borderline ovarian tumors (BOT) and normal ovarian tissues. This reduced expression is associated with increased cell proliferation and tumor growth, suggesting that KNDC1 acts as a tumor suppressor. Its expression levels are linked to progression-free survival in OC patients, indicating its potential as a prognostic marker (p&gt; Yu2020&lt; KNDC1).

In the context of endothelial cell senescence, KNDC1 expression increases with cell aging. Overexpression of KNDC1 in human umbilical vein endothelial cells (HUVECs) promotes senescence through a p53-ROS positive feedback loop, while its knockdown delays senescence and enhances cell function. This suggests that KNDC1 plays a role in vascular aging and could be a target for anti-senescence therapies (Ji2018Effect; ZHANG2014KNDC1).

KNDC1 has also been identified as a frequently methylated gene in certain leukemias, such as acute myeloid leukemia, where it may act as a tumor suppressor. Its methylation status could be relevant for understanding cancer progression and resistance to chemotherapy (Dunwell2010A).

## Interactions
KNDC1 (kinase non-catalytic C-lobe domain containing 1) is involved in various protein-protein interactions that influence cellular processes. It is known to interact with high-molecular weight microtubule-associated protein 2 (MAP2), which plays a role in the negative regulation of neuronal dendrite growth (Duan2016Genetic; ZHANG2014KNDC1). This interaction is significant in the context of dendritic development and neuronal signaling pathways.

In the context of endothelial cell senescence, KNDC1 is involved in the regulation of the p53 signaling pathway. Overexpression of KNDC1 in human umbilical vein endothelial cells (HUVECs) leads to increased phosphorylation of p53, a key regulator of the DNA damage response and cell cycle arrest (Ji2018Effect). This interaction suggests a role for KNDC1 in modulating cellular aging processes through the p53 pathway.

KNDC1 is also implicated in the ERK1/2 signaling pathway in ovarian cancer cells. Its knockdown results in increased ERK1/2 phosphorylation, promoting cell proliferation, while overexpression reduces ERK1/2 activity, indicating a potential tumor suppressor role for KNDC1 through this pathway (p&gt; Yu2020&lt; KNDC1). These interactions highlight KNDC1's involvement in critical signaling pathways that regulate cell growth and differentiation.


## References


[1. (Ji2018Effect) Jinrui Ji, Zhenxuan Hao, Hengliang Liu, Yang Liu, Jing Liu, Binghui Lin, Chao Ma, and Yajun Lin. Effect of kndc1 overexpression on the senescence of human umbilical vein endothelial cells. Molecular Medicine Reports, March 2018. URL: http://dx.doi.org/10.3892/mmr.2018.8775, doi:10.3892/mmr.2018.8775. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2018.8775)

[2. (Duan2016Genetic) Zhongyi Duan, Congjiao Sun, ManMan Shen, Kehua Wang, Ning Yang, Jiangxia Zheng, and Guiyun Xu. Genetic architecture dissection by genome-wide association analysis reveals avian eggshell ultrastructure traits. Scientific Reports, July 2016. URL: http://dx.doi.org/10.1038/srep28836, doi:10.1038/srep28836. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep28836)

[3. (Dunwell2010A) Thomas Dunwell, Luke Hesson, Tibor A Rauch, Lihui Wang, Richard E Clark, Ashraf Dallol, Dean Gentle, Daniel Catchpoole, Eamonn R Maher, Gerd P Pfeifer, and Farida Latif. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers. Molecular Cancer, February 2010. URL: http://dx.doi.org/10.1186/1476-4598-9-44, doi:10.1186/1476-4598-9-44. This article has 83 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1476-4598-9-44)

[4. (Hayashi2017The) Kanehiro Hayashi, Asako Furuya, Yuriko Sakamaki, Takumi Akagi, Yo Shinoda, Tetsushi Sadakata, Tsutomu Hashikawa, Kazuki Shimizu, Haruka Minami, Yoshitake Sano, Manabu Nakayama, and Teiichi Furuichi. The brain-specific rasgef very-kind is required for normal dendritic growth in cerebellar granule cells and proper motor coordination. PLOS ONE, 12(3):e0173175, March 2017. URL: http://dx.doi.org/10.1371/journal.pone.0173175, doi:10.1371/journal.pone.0173175. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0173175)

[5. (ZHANG2014KNDC1) CHUNYAN ZHANG, YONG-ZHAN ZHEN, YA-JUN LIN, JIANG LIU, JIE WEI, RONG XU, and GANG HU. Kndc1 knockdown protects human umbilical vein endothelial cells from senescence. Molecular Medicine Reports, 10(1):82–88, April 2014. URL: http://dx.doi.org/10.3892/mmr.2014.2201, doi:10.3892/mmr.2014.2201. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2014.2201)